Trial Details

COMPLETED
Basic Information
Clinical ID c1576
Identifier NCT02306785
Trial Title TP0502-Pharmaco-Scintigraphic-Study and Amendment
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: TP05 Coating D|DRUG: TP05 Coating E|DRUG: TP05 Coating H
Participant Information
Sponsor Tillotts Pharma AG
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-10-12
Primary Completion Date 2025-02-13
Completion Date 2025-06-13